XML 15 R5.htm IDEA: XBRL DOCUMENT v3.20.2
Statements of Stockholders' Equity (Unaudited) - USD ($)
Common Stock [Member]
Additional Paid-in Capital [Member]
Accumulated Deficit [Member]
Total
Balance at Dec. 31, 2018 $ 15,639 $ 127,290,467 $ (114,386,401) $ 12,919,705
Balance, shares at Dec. 31, 2018 15,638,765      
Stock-based compensation expense 442,781 442,781
Exercise of stock options, net of cashless exercise of shares $ 58 63,192 63,250
Exercise of stock options, net of cashless exercise of shares, shares 58,008      
Exercise of warrants $ 93 204,190 204,283
Exercise of warrants, shares 92,856      
Issuance of shares for restricted stock grants $ 2 (2)
Issuance of shares for restricted stock grants, shares 2,000      
Net loss (2,086,668) (2,086,668)
Balance at Jun. 30, 2019 $ 15,792 128,000,628 (116,473,069) 11,543,351
Balance, shares at Jun. 30, 2019 15,791,629      
Balance at Mar. 31, 2019 $ 15,639 127,660,206 (115,599,392) 12,076,453
Balance, shares at Mar. 31, 2019 15,638,765      
Stock-based compensation expense 73,042 73,042
Exercise of stock options, net of cashless exercise of shares $ 58 63,192 63,250
Exercise of stock options, net of cashless exercise of shares, shares 58,008      
Exercise of warrants $ 93 204,190 204,283
Exercise of warrants, shares 92,856      
Issuance of shares for restricted stock grants $ 2 (2)
Issuance of shares for restricted stock grants, shares 2,000      
Exercise of stock options
Exercise of stock options, shares      
Net loss (873,677) (873,677)
Balance at Jun. 30, 2019 $ 15,792 128,000,628 (116,473,069) 11,543,351
Balance, shares at Jun. 30, 2019 15,791,629      
Balance at Dec. 31, 2019 $ 16,042 128,668,583 (116,935,112) 11,749,513
Balance, shares at Dec. 31, 2019 16,041,650      
Stock-based compensation expense 189,752 189,752
Exercise of stock options, net of cashless exercise of shares $ 147 139,111 139,258
Exercise of stock options, net of cashless exercise of shares, shares 146,957      
Exercise of warrants $ 50 109,950 110,000
Exercise of warrants, shares 50,000      
Issuance of shares for restricted stock grants $ 13 (13)
Issuance of shares for restricted stock grants, shares 12,995      
Issuance of common stock, net of costs $ 1,769 10,567,698 10,569,467
Issuance of common stock, net of costs, shares 1,769,230      
Settlement of executive bonuses with issuance of restricted stock units $ 9 53,451 53,460
Settlement of executive bonuses with issuance of restricted stock units, shares 9,462      
Shares forfeited in exchange for withholding taxes $ (2) (13,335) (13,337)
Shares forfeited in exchange for withholding taxes, shares (2,012)      
Net loss (733,671) (733,671)
Balance at Jun. 30, 2020 $ 18,028 139,715,197 (117,668,783) 22,064,442
Balance, shares at Jun. 30, 2020 18,028,282      
Balance at Mar. 31, 2020 $ 16,210 128,989,744 (116,908,510) 12,097,444
Balance, shares at Mar. 31, 2020 16,209,627      
Stock-based compensation expense 103,710 103,710
Exercise of stock options, net of cashless exercise of shares $ 32 13,939 13,971
Exercise of stock options, net of cashless exercise of shares, shares 31,650      
Issuance of shares for restricted stock grants $ 10 (10)
Issuance of shares for restricted stock grants, shares 10,325      
Issuance of common stock, net of costs $ 1,769 10,567,698 10,569,467
Issuance of common stock, net of costs, shares 1,769,230      
Settlement of executive bonuses with issuance of restricted stock units $ 9 53,451 53,460
Settlement of executive bonuses with issuance of restricted stock units, shares 9,462      
Shares forfeited in exchange for withholding taxes $ (2) (13,335) (13,337)
Shares forfeited in exchange for withholding taxes, shares (2,012)      
Net loss (760,273) (760,273)
Balance at Jun. 30, 2020 $ 18,028 $ 139,715,197 $ (117,668,783) $ 22,064,442
Balance, shares at Jun. 30, 2020 18,028,282